October 8, 2012

Diabetes: To Cure or not To Cure


A very interesting editorial was written explaining the flawed reasoning as to why pharmaceutical companies are not in bed to prevent finding a cure for diabetes.

We can think of the relationship, for lack of a better term, between the pharmaceutical companies and cure researchers as contradictory. One side butters their bread as long as diabetes exists, the other side wants to cure diabetes. Needless to say you won’t see either party sitting across from each other at Thanksgiving dinner.

The reality today is that no company or corporation has cured any disease – ever. At the end of the day, companies that are publically held are in place to be profitable for shareholders. The loyalty lies within the goals of the company to its owners. The three largest companies that own diabusiness are Eli Lilly, Sanofi, and Novo Nordisk. All three corporations create profits based on drugs to treat diabetes, not to cure the disease.

When it comes to stealing from the rich pharmaceutical companies and giving to the poor people with diabetes, we may not have a Robin Hood. The evolution of diabetes treatment has made a scalar jump in the last two decades compared to the previous century. This advancement was due to the pharmaceutical companies and their relentless pursuit of the all-mighty dollar.

What if the idea of a cure is actually the concept of being able to live life with a disease like diabetes, uninterrupted? If I were a betting woman, I would bet that the industry leaders in diabetes will find a way to reap the windfall when diabetes is “cured”.¬†As sure as the sun rises in the East, companies will profit from diabetes – cured or not.

Visit Your Diabetes Health for more resources about health.